CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials (Q42108657)
Jump to navigation
Jump to search
scientific article published on 24 March 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials |
scientific article published on 24 March 2017 |
Statements
1 reference
CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials (English)
1 reference
Ann Lin
1 reference
Christopher J Giuliano
1 reference
Nicole M Sayles
1 reference
Jason M Sheltzer
1 reference
24 March 2017
1 reference